EMERGENT BIOSOLUTIONS INC (EBS)

US29089Q1058 - Common Stock

2.29  +0.13 (+6.02%)

After market: 2.29 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.05B1.12B1.77B1.56B1.11B
Cost Of Goods
705.40M693.10M748.10M506.70M433.50M
Gross Profit
343.90M424.40M1.03B1.05B672.50M
Operating Expenses
545.40M587.70M642.40M568.60M558.40M
Research and Development
111.40M188.30M235.20M205.50M226.20M
Selling, General, and Administrative Expenses
368.40M339.50M348.70M303.30M273.50M
Operating Income
-201.50M-163.30M383.10M480.10M114.10M
Interest Income/Expense
-87.90M-37.30M-34.50M-31.30M-38.40M
Other Income/Expense
8.90M-11.70M-3.70M4.70M1.70M
Non Recurring Items
-450.70M-6.70M-41.70M-46.30MN/A
Income Before Taxes
-731.20M-219.00M303.20M407.20M77.40M
Income Tax
29.30M-7.40M83.70M102.10M22.90M
Net Income
-760.50M-211.60M219.50M305.10M54.50M
EBITDA
-76.40M-20.00M506.90M594.60M224.80M
 
Per Share Data
EPS Diluted Total Ops
-14.85-4.224.065.671.04
Non GAAP EPS
-5.48-2.266.007.852.77
 
Statistics
Gross Profit Margin
32.77%37.98%57.82%67.42%60.80%
Profit Margin
-72.48%-18.94%12.38%19.62%4.93%
Operating Profit Margin
-19.20%-14.61%21.60%30.87%10.32%

All data in USD

Charts